Please login to the form below

Not currently logged in
Email:
Password:

NBE-Therapeutics

This page shows the latest NBE-Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Boehringer spends €1.18bn to acquire NBE-Therapeutics

Boehringer spends €1.18bn to acquire NBE-Therapeutics

NBE-Therapeutics, headquartered in Switzerland, is focused on antibody-drug conjugates (ADC) for the development of targeted cancer therapies. ... NBE-Therapeutics’ iADC platform adds exceptional tumour targeting capabilities to our oncology portfolio.

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...